United Kingdom Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers United Kingdom blood glucose monitoring market company share and it is segmented by type (self-monitoring blood glucose devices and continuous glucose monitoring devices) and components (glucometer devices, test strips, lancets, sensors, and durables). The report offers the value (in USD million) and volume (in units million) for the above segments.

United Kingdom Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

United Kingdom Blood Glucose Monitoring Market Size

View Global Report
United Kingdom Blood Glucose Monitoring Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 604.16 Million
Market Size (2030) USD 904.27 Million
CAGR (2025 - 2030) 8.40 %
Market Concentration Medium

Major Players

United Kingdom Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of United Kingdom Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

United Kingdom Blood Glucose Monitoring Market Analysis

The United Kingdom Blood Glucose Monitoring Market size is estimated at USD 604.16 million in 2025, and is expected to reach USD 904.27 million by 2030, at a CAGR of 8.4% during the forecast period (2025-2030).

One of the most significant risk factors for a severe course of COVID-19 is diabetes mellitus. This risk is believed to be influenced by several variables that are frequently present in diabetes mellitus, such as advanced age, a proinflammatory and hypercoagulable condition, hyperglycemia, and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease, and obesity). Diabetes was quickly recognized as a risk factor for bad results during the COVID-19 pandemic. That's why managing or delaying cases of type 2 diabetes became more important than ever before. Several studies have confirmed that chronic diseases like diabetes are associated with adverse outcomes in COVID-19 patients.

Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and, thus, incur more healthcare expenses compared to non-diabetic people. People with diabetes face a higher chance of experiencing serious complications from COVID-19. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus. Diabetes and high glucose levels are associated with increased complications, respiratory failure, and mortality in hospitalized patients with coronavirus.

According to The British Diabetic Association, 'The pandemic has had, and continues to have, a huge impact on our society. But research and data have shown that people with diabetes have been disproportionately affected by COVID-19, particularly in terms of poorer outcomes when contracting the virus. That's why preventing or delaying cases of type 2 diabetes is more important than ever before.' 

The pandemic also highlighted opportunities for continuing and expanding innovations in the delivery of diabetes care, through virtual consultations between healthcare providers and people with diabetes, and the use of diabetes technology. Crisis management has created unprecedented interest in remote care from both patients and providers and removed many long-standing regulatory barriers. Thus, the COVID-19 outbreak increased the blood glucose monitoring market's growth.

United Kingdom Blood Glucose Monitoring Industry Overview

The United Kingdom blood glucose monitoring market is moderately fragmented, with few significant and generic players. There have been constant innovations driven by manufacturers such as Abbott, Dexcom, Medtronic, etc. while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.

United Kingdom Blood Glucose Monitoring Market Leaders

  1. Lifescan

  2. Dexcom

  3. Roche Diabetes Care

  4. Abbott Diabetes Care

  5. Ascensia Diabetes Care

  6. *Disclaimer: Major Players sorted in no particular order
United Kingdom Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

United Kingdom Blood Glucose Monitoring Market News

  • September 2023: Medtronic received the CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera continuous glucose monitor (CGM) featuring a simple, two-step insertion process. The no-fingerstick sensor does not require overtape and is seamlessly integrated with the InPen smart insulin pen, which provides real-time, personalized dosing guidance to help simplify diabetes management.
  • June 2023: Afon Technology, a Welsh-based med-tech startup, is working to develop Glucowear, a non-invasive, real-time, continuous wearable glucose monitor.

United Kingdom Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Self-monitoring blood glucose devices
    • 5.1.1.1 Glucometer Devices
    • 5.1.1.2 Test Strips
    • 5.1.1.3 Lancets
    • 5.1.2 Continuous blood glucose monitoring devices
    • 5.1.2.1 Sensors
    • 5.1.2.2 Durables (Receivers and Transmitters)
  • 5.2 Distribution Channel
    • 5.2.1 Online
    • 5.2.2 Offline

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Diabetes Care
    • 7.1.3 LifeScan
    • 7.1.4 Dexcom Inc.
    • 7.1.5 Medtronic PLC
    • 7.1.6 Arkray Inc.
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon Laboratories Inc.
    • 7.1.11 Trivida Health
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS
    • 7.2.1 Self-monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche Diabetes Care
    • 7.2.1.3 LifeScan
    • 7.2.1.4 Other Self-monitoring Blood Glucose Devices
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom Inc.
    • 7.2.2.2 Medtronic PLC
    • 7.2.2.3 Abbott Diabetes Care
    • 7.2.2.4 Other Continuous Glucose Monitoring Devices

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

United Kingdom Blood Glucose Monitoring Industry Segmentation

Blood glucose monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients. The United Kingdom's blood glucose monitoring market is segmented into types and components. The report offers the value (in USD) and volume (in units) for the above segments.

Type Self-monitoring blood glucose devices Glucometer Devices
Test Strips
Lancets
Continuous blood glucose monitoring devices Sensors
Durables (Receivers and Transmitters)
Distribution Channel Online
Offline
Need A Different Region or Segment?
Customize Now

United Kingdom Blood Glucose Monitoring Market Research FAQs

How big is the United Kingdom Blood Glucose Monitoring Market?

The United Kingdom Blood Glucose Monitoring Market size is expected to reach USD 604.16 million in 2025 and grow at a CAGR of 8.40% to reach USD 904.27 million by 2030.

What is the current United Kingdom Blood Glucose Monitoring Market size?

In 2025, the United Kingdom Blood Glucose Monitoring Market size is expected to reach USD 604.16 million.

Who are the key players in United Kingdom Blood Glucose Monitoring Market?

Lifescan, Dexcom, Roche Diabetes Care, Abbott Diabetes Care and Ascensia Diabetes Care are the major companies operating in the United Kingdom Blood Glucose Monitoring Market.

What years does this United Kingdom Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the United Kingdom Blood Glucose Monitoring Market size was estimated at USD 553.41 million. The report covers the United Kingdom Blood Glucose Monitoring Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the United Kingdom Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

United Kingdom Blood Glucose Monitoring Industry Report

Statistics for the 2025 United Kingdom Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. United Kingdom Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

United Kingdom Blood Glucose Monitoring Market Report Snapshots